K152693

Substantially Equivalent

CLEARSIGN II Amplifier 40 Channels, CLEARSIGN II Amplifier 80 Channels, CLEARSIGN II Amplifier 120 Channels, CLEARSIGN II Amplifier 160 Channels

Applicant: Boston Scientific Corporation
Product code: DRQ
Advisory panel: Cardiovascular
Date received: 2015-09-21
Decision date: 2015-10-21
Decision: Substantially Equivalent
Clearance type: Special
Location: Lowell, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.